Capitalization 21.51B 14.24B P/E ratio 2024 *
55.5x
P/E ratio 2025 * 49.4x
Enterprise value 14.69B 9.73B EV / Sales 2024 *
9.22x
EV / Sales 2025 * 8.44x
Free-Float
99.37%
Yield 2024 *
1.27%
Yield 2025 * 1.44%
More valuation ratios * Estimated data
Dynamic Chart
1 day+2.92%
1 week+1.26%
Current month+1.77%
1 month+4.41%
3 months+4.69%
6 months+11.94%
Current year+13.18%
More quotes
1 week
318.39
Extreme 318.39
340.34
1 month
313.62
Extreme 313.62
340.78
Current year
283.70
Extreme 283.7
350.17
1 year
230.01
Extreme 230.01
350.17
3 years
178.55
Extreme 178.545
350.17
5 years
154.60
Extreme 154.6
350.17
10 years
62.40
Extreme 62.4
350.17
More quotes
Manager TitleAgeSince
Chief Executive Officer - 99-12-31
Director of Finance/CFO - 16-04-30
Chief Tech/Sci/R&D Officer - 23-04-30
Director TitleAgeSince
Director/Board Member 60 14-12-31
Chairman 56 15-01-31
Chief Executive Officer - 99-12-31
More insiders

Medical Prosthetics

Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+2.92%+1.26%+43.98%+37.38% 14.28B
-0.11%-2.14%+11.33%-24.65% 17.83B
-0.20%-15.81%-6.89%-31.63% 7.99B
+5.57%+19.47%-24.90%-52.50% 2.06B
+3.07%+5.59%-5.18%-37.15% 1.82B
-2.84%-3.52%-19.41%-88.11% 1.22B
+2.94%+3.96%+28.44%-40.17% 494M
-2.65%-8.14% - - 316M
+1.09%+4.52%+69.80%-13.24% 231M
-1.18%-5.26%+196.47%-38.08% 92.22M
Average +0.86%-0.68%+32.63%-32.02% 4.63B
Weighted average by Cap. +1.13%-3.70%+16.05%-10.18%
See all sector performances
Ratios2024 *2025 *
Net sales 2.28B 1.51B 2.48B 1.64B
Net income 390M 259M 441M 292M
Net Debt -514M -341M -592M -392M
More financial data * Estimated data
Logo Cochlear Limited
Cochlear Limited is an Australia-based company, which provides implantable hearing solutions and sound processors. The Company is engaged in development, manufacture and commercialization of implantable hearing solutions. Its segments include Cochlear implants, Services (sound processor upgrades and other) and Acoustics. The Company’s products and services portfolio include Cochlear implant portfolio, Acoustic solutions portfolio, and Recipient support tools. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check solution for cochlear implants. Its Cochlear implant portfolio include Cochlear Nucleus System. Its Acoustic solutions portfolio include Cochlear Osia System, and Cochlear Baha System. Its Recipient support tools include Cochlear Nucleus, Baha and Osia Smart Apps and Cochlear CoPilot App.
Employees
4,800
Calendar
Related indices
More about the company
Date Price Change Volume
24-07-23 338.04 $ +2.92% 108 066
24-07-22 328.44 $ +1.43% 83,390
24-07-19 323.80 $ -2.93% 147,826
24-07-18 333.59 $ -1.17% 137,597
24-07-17 337.54 $ +1.11% 94,054

Delayed Quote Australian S.E., July 23, 2024 at 02:10 am EDT

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
16
Last Close Price
328.44AUD
Average target price
280.85AUD
Spread / Average Target
-14.49%
Consensus